Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Davidson

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Journal of Cardiovascular Pharmacology|July 30, 2019
Role of Caspase 1 in Ischemia/Reperfusion Injury of the MyocardiumAli Rauf, Mo Shah, Derek M Yellon, et al.
Cardiovascular Drugs and Therapy|January 4, 2025
Novel Selective Cardiac Myosin-Targeted Inhibitors Alleviate Myocardial Ischaemia-Reperfusion InjuryNur Liyana Mohammed Yusof, Derek M Yellon, Sean M Davidson
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2014
Endothelial insulin resistance protects the heart against prolonged ischemia-reperfusion injury but does not prevent insulin transport across the endothelium in a mouse Langendorff modelVikram Sharma, Mark T Kearney, Sean M Davidson, et al.
Cardiovascular Research|March 14, 2019
Shining the spotlight on cardioprotection: beyond the cardiomyocyteSean M Davidson, Ioanna Andreadou, David Garcia-Dorado, et al.
Journal of Cellular and Molecular Medicine|November 22, 2017
Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusionXavier Rossello, Jaime A Riquelme, Sean M Davidson, et al.
The International Journal of Biochemistry & Cell Biology|November 11, 2005
Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotectionSean M Davidson, Derek Hausenloy, Michael R Duchen, et al.
The Journal of Endocrinology|January 9, 2016
Microvesicles and exosomes: new players in metabolic and cardiovascular diseaseCharlotte Lawson, Jose M Vicencio, Derek M Yellon, et al.
Cardiovascular Drugs and Therapy|October 27, 2022
Nicorandil - an Effective Multitarget Drug for Cardioprotection?Lucie Pearce, Richard D Carr, Derek M Yellon, et al.
Cardiovascular Research|December 27, 2011
Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenationSean M Davidson, Derek M Yellon, Michael P Murphy, et al.
Cardiovascular Drugs and Therapy|May 17, 2018
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K PathwayAngshuman Maulik, Sean M Davidson, Izabela Piotrowska, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Journal of Cardiovascular Pharmacology|July 30, 2019
Role of Caspase 1 in Ischemia/Reperfusion Injury of the MyocardiumAli Rauf, Mo Shah, Derek M Yellon, et al.
Cardiovascular Drugs and Therapy|January 4, 2025
Novel Selective Cardiac Myosin-Targeted Inhibitors Alleviate Myocardial Ischaemia-Reperfusion InjuryNur Liyana Mohammed Yusof, Derek M Yellon, Sean M Davidson
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2014
Endothelial insulin resistance protects the heart against prolonged ischemia-reperfusion injury but does not prevent insulin transport across the endothelium in a mouse Langendorff modelVikram Sharma, Mark T Kearney, Sean M Davidson, et al.
Cardiovascular Research|March 14, 2019
Shining the spotlight on cardioprotection: beyond the cardiomyocyteSean M Davidson, Ioanna Andreadou, David Garcia-Dorado, et al.
Journal of Cellular and Molecular Medicine|November 22, 2017
Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusionXavier Rossello, Jaime A Riquelme, Sean M Davidson, et al.
The International Journal of Biochemistry & Cell Biology|November 11, 2005
Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotectionSean M Davidson, Derek Hausenloy, Michael R Duchen, et al.
The Journal of Endocrinology|January 9, 2016
Microvesicles and exosomes: new players in metabolic and cardiovascular diseaseCharlotte Lawson, Jose M Vicencio, Derek M Yellon, et al.
Cardiovascular Drugs and Therapy|October 27, 2022
Nicorandil - an Effective Multitarget Drug for Cardioprotection?Lucie Pearce, Richard D Carr, Derek M Yellon, et al.
Cardiovascular Research|December 27, 2011
Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenationSean M Davidson, Derek M Yellon, Michael P Murphy, et al.
Cardiovascular Drugs and Therapy|May 17, 2018
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K PathwayAngshuman Maulik, Sean M Davidson, Izabela Piotrowska, et al.
Pageof 18